Gamma Medica raises $16M Series A; Terumo launches brain stent study;

 @FierceMedDev: Med tech VC investing remains sluggish, biotech surges. Report | Follow @FierceMedDev

 @MarkHFierce: Google is backing Dx company SynapDx in its new $15.4M funding round. Release (PDF) | Follow @MarkHFierce

 @DamianFierce: Mela's melanoma-finding device was hailed as a major advance on FDA approval, but docs remain wary. Story | Follow @DamianFierce

> Omar Ishrak's strategies for revamping Medtronic ($MDT) during his first two years as CEO are drawing attention and raves. Story

> Gamma Medica nailed down a $16 million Series A funding round toward expanded commercialization of its molecular imaging system for dense breast tissue and a companion biopsy module. Item

> Terumo has kicked off a U.S. trial of its FRED flow diversion system to treat intracranial aneurysms. News

> The FDA has assigned its most serious warning to Bryan Medical's recall of a tracheostomy tube, warning that a packaging error could put patients in danger. More

> Australia's Saluda Medical nailed down $4.6 million in new funding toward development of an electronic stimulation device to treat chronic pain. Story

> Stryker ($SYK) scored high in a recent Gallup poll that measured employee engagement. Story

> Israel's ETView Medical has inked an exclusive distribution deal with MEDITRADE that will give its ViviSight ventilation tube/airway imaging devices access to markets in Slovakia, the Czech Republic and Poland. Item

> Startup Curvo Labs in Indiana scored some initial funding for a product that would connect hospitals and medical device companies via big data. Story

> HistoGenetics will use Illumina's ($ILMN) MiSeq sequencing system in its CLIA laboratory to help test for HLA gene variations, which are connected to many autoimmune and infectious diseases, plus some cancers. Item

Biotech News

 @FierceBiotech: Popular this weekend - Report: Pfizer backs off Onyx bid as price gets too rich. Article | Follow @FierceBiotech

 @JohnCFierce:  Report: Big Pharma mounts secret attack against data transparency rule - (some companies will never learn). Report | Follow @JohnCFierce

 @RyanMFierce: Roche is still undecided about new chair. Art Levinson dismissed as "too radical." Reutersarticle | Follow @RyanMFierce

 @EmilyMFierce: New 3-D model of diabetes target could shape drug design. More | Follow @EmilyMFierce

> Does Roche need a biotech brain in the chairman's office? Story

> Isis Pharma fuels fervor for cardio drug with more midstage data. Report

> Biotech vets pick up $10M B round for startup Alcresta. News

Pharma News

 @FiercePharma: Chinese police pick up AstraZeneca sales rep for questioning. AZN says no reason to think it's part of bribery probe. Report | Follow @FiercePharma

 @CarlyHFierce: Reuters says Roche may have to turn to an outsider for its chairman hunt. News | Follow @CarlyHFierce

> Chile's CFR wins shareholder OK for Adcock buyout financing. Story

> GlaxoSmithKline exec admits "breaches," promises price cuts in China. Article

CRO News

> ResearchDx expands to meet contract diagnostics demand. Report

> CROs large and small get serious about eClinical. More

> Aesica teams with QRxPharma for abuse-deterrence tech. Item

> CRO Solutions spins niche services into new biz. Story

> AstraZeneca picks Tufts for outsourcing-heavy neuro program. Article

> WuXi, PRA snag ex-Theorem CEO to head China JV. News

Biotech IT News

> J&J searching for European digital health entrepreneurs. Item

> Chinese CRO buys software to bridge gap to global clients. More

> Bioinformatics buy bolsters Life Technologies' diagnostics pact with Merck Serono. Story

> With pharma clientele, Big Data-mapping startup Ayasdi lands $30.6M financing. Article

Suggested Articles

Sherlock Biosciences teamed up with Cepheid to help develop its CRISPR-based molecular diagnostic tech in oncology, infections and the coronavirus.

The spine surgery company ATEC has moved to acquire Paris-based EOS imaging, makers of FDA-cleared scanners and 3D orthopedic planning software.

Digital molecule designer Insilico Medicine has launched a new preclinical research program focused on treatments for brain cancer.